12:00 AM
Mar 23, 1998
 |  BC Week In Review  |  Clinical News  |  Clinical Status

AnergiX:ANRG and partner N.V. Organon filed an IND with the FDA to begin a Phase I trial of AnergiX

(ANRG receives milestone, B2)

Anergen Inc. (ANRG), Redwood City, Calif.
Product: AnergiX delivery technology combined with a peptide derived from...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >